This compound is a pharmaceutical intermediate used as a precursor in the synthesis of active pharmaceutical ingredients. It features a methyl glycidate ester group and a benzodioxole ring, contributing to its role in organic synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Controlled substances
Substances on this list are tightly controlled under chemical-weapons or precursor regulations. ChemAbout does not facilitate their procurement; this page is a compliance reference only.
CAS 13605-48-6
Ethyl 3-(2H-1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate
pharmaceutical intermediate
PMK glycidic acid
research compound
Tert-butyl (S)-(1-cyclopropyl-2-hydroxyethyl)carbamate
pharmaceutical intermediate
(1R,2R)-1-amino-2-difluoromethyl)-N-(1-methylcyclopropylsulfonyl)cyclo propanecarboxyamide hydrochloride
pharmaceutical intermediate
Ethyl 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
pharmaceutical intermediate
Sodium (R)-3-hydroxybutanoate
pharmaceutical intermediate
The international HS code for 3,4-MDP-2-P METHYL GLYCIDATE (CAS 13605-48-6) is 2932.99.
2932.99
2932 99 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate
NEWFBAYQRLTJTP-UHFFFAOYSA-N
CC1(C(O1)C2=CC3=C(C=C2)OCO3)C(=O)OC